In Brief
A protein marker-based, genome-wide CRISPR screen has been developed in primary immune cells to identify genes that control the induction of tumor necrosis factor. Many of the known regulators, as well as dozens of previously unknown candidates, have been identified, individually validated, and classified into three functional modules.
Accession Numbers GSE67164

INTRODUCTION
Regulatory circuits that control gene expression in response to extracellular signals perform key information processing roles in mammalian cells, but their systematic unbiased reconstruction remains a fundamental challenge. There are currently two major strategies for associating targets with their putative regulators on a genomic scale (reviewed in Kim et al., 2009 ): (1) observational (correlative) approaches that relate them based on statistical dependencies in their quantities or physical associations and (2) perturbational (causal) approaches that relate them by the effect that a perturbation in a putative regulator has on its target.
While observational strategies have become a cornerstone of circuit inference from genomic data, perturbational strategies have been more challenging to apply on a genomic scale, especially in primary mammalian cells. RNAi, which until recently was the main tool available in mammals, is limited by off-target effects and lack of sufficient suppression of expression (Echeverri et al., 2006) , whereas more effective strategies based on haploid cell lines (Carette et al., 2009) are not applicable to the diversity of primary cell types and their specialized circuitry. As a result, a hybrid approach has emerged (Amit et al., 2011) , where genomic profiles (e.g., of mRNAs, protein-DNA binding, protein levels, protein phosphorylation, etc.) are used to build observational models from which a smaller set of dozens of candidate regulators are identified. These candidates are in turn tested by perturbation.
The recent introduction of genome editing in mammalian cells using the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated nuclease Cas9 system has enabled pooled genome-wide screens of gene function (Gilbert et al., 2014; Konermann et al., 2015; Shalem et al., 2014; Wang et al., 2014) . In such screens, pooled libraries are introduced into cell lines and cellular phenotypes are selected based on cell lethality or growth. To expand the biological processes that can be studied, there remains a need to adapt these methods for short-term primary cell cultures and selecting cellular phenotypes based on more versatile molecular markers.
Here, we present a pooled CRISPR strategy to dissect the innate immune response of bone-marrow-derived dendritic cells (BMDCs, or DCs) isolated from Cas9-expressing transgenic mice. Building on our recent observation that lentiviruses expressing single-guide RNAs (sgRNAs) could be used to knock out genes in these cells (Platt et al., 2014) , we infected DCs with a pooled, genome-wide library of lentiviruses, stimulated them with lipopolysaccharide (LPS), and monitored their responses by intra-cellular staining for the inflammatory cytokine Tnf, a major marker of the early response to LPS. We used flow cytometry to isolate cells that failed to fully induce Tnf or that induced it more strongly, and then we determined sgRNA abundance by deep sequencing. We recovered many of the key known regulators of TLR signaling, validated dozens of new regulators, and identified three functional modules of regulators with distinct regulatory effects. Our study identifies new facets in the complex response of immune cells to pathogens and provides a general strategy for systematically dissecting circuits in other primary mammalian cells.
RESULTS
A System for Cell-Autonomous, Pooled Genetic Screens in BMDCs Derived from Cas9-Expressing Mice To enable genome-wide pooled genetic screens, we developed a cell-autonomous readout of innate immune activation by intracellular staining of a central inflammatory cytokine, Tnf. To test the assay, we individually transduced BMDCs with lentiviruses expressing sgRNAs (Experimental Procedures) that target each of three genes: (1) Tlr4, the cell membrane receptor that senses bacterial LPS; (2) Myd88, a key component required for Tlr4 signaling to induce Tnf; and (3) Zfp36 (TTP), an RNA-binding protein that destabilizes Tnf mRNA. Following LPS activation, we added Brefeldin A to block Tnf secretion and at 8 hr post-activation detected Tnf with a fluorescent antibody using flow cytometry. Compared to a non-targeting sgRNA control, sgRNAs targeting Myd88 or Tlr4 strongly reduced Tnf, whereas sgRNAs targeting Zfp36 increased Tnf ( Figure 1A) . These results provide (E) CDFs of screen ranks for the 35 genes in the TLR pathway from LPS to Tnf (KEGG, blue), non-targeting controls (black), and all other genes (gray). See also Figure S1 .
an experimental system in BMDCs for an autonomous genomewide pooled screen based on cell sorting.
A Genome-wide Pooled sgRNA Library Screen in Primary BMDCs We performed three independent, pooled genome-wide screens using a library of lentiviruses harboring 125,793 sgRNAs targeting 21,786 annotated protein-coding and miRNA mouse genes , as well as 1,000 non-targeting sgRNA as negative controls. In each of the three replicate screens, we infected 60-200 million BMDCs with the library at a multiplicity of infection (MOI) of 1, stimulated cells with LPS, and sorted Cd11c+ cells based on high or low Tnf expression levels ($5 million cells/bin; Figure 1B and Experimental Procedures). We then amplified and sequenced sgRNAs from four sources ( Figure 1B , thick gray arrows): post-LPS cells with (1) high Tnf (''Tnf hi '') or with (2) low Tnf (''Tnf lo ''), (3) cells from the last day of differentiation prior to LPS stimulation (day 9, ''pre-LPS''), and (4) plasmid DNA of the input lentiviral library (''Input''). We reasoned that sgRNAs against positive regulators of Tnf expression would be enriched in Tnf lo relative to Tnf hi , that sgRNAs targeting negative regulators will be enriched in Tnf hi relative to Tnf lo , and that sgRNAs targeting genes essential for DC viability or differentiation would be depleted in pre-LPS compared to Input. We established two computational methods to address the inherent noise of the screen ( Figure S1A ): the first using Z scores (ZS) of the fold change in normalized sgRNA abundance (and then averaging the top four sgRNAs per gene) and the second analogous to differential expression (DE) analysis of sequenced RNA (Love et al., 2014; Experimental Procedures) . The top-ranked genes substantially overlap between the two approaches (50/100 for positive regulators, 30/100 for negative regulators, p < 10 À10 , hypergeometric test), and their rankings are well correlated (Figures S1B and S1C) up to ranks 150 and 50 for positive and negative regulators, respectively (Figures S1D and S1E). While our screen is in principle compatible with discovery of both positive and negative regulators, it was conducted at high (near-saturation) levels of LPS and is thus likely to be less sensitive for discovery of negative regulators due to limited dynamic range for observing further Tnf induction.
The Screen Correctly Identifies Known Regulators of Cell Viability, Differentiation, Tnf Expression, and Tlr4 Signaling To assess the initial quality of our screen and scoring scheme, we first determined that, as expected, sgRNAs against ''essential'' genes (Hart et al., 2014) were depleted in pre-LPS samples compared to Input ( Figure 1C , Figure S1F , and Figure 1D and Table S1 ; DE analysis, Figure S1G and Table S1 ). The top-ranked genes were highly enriched for those annotated as responsive to LPS (the highest-scoring category; GOrilla, false discovery rate [FDR] q val = 10
À12
; Eden et al., 2009) or assigned to the Tlr4-to-Tnf pathway (in KEGG; Kanehisa and Goto, 2000, Figure 1E , and Experimental Procedures); they were also far more likely to be expressed ( Figure S1H, Table S1 ). The top 10 ranked positive regulator genes were almost exclusively populated by the hallmark members of TLR signaling, with many others among the top 100, showing that an unbiased, genome-wide screen can decipher near-complete pathways ( Figure 2B and Table S1 ). Tnf had the top rank, demonstrating the screen's quantitative nature. Key regulators of the LPS response with high ranks in our screen included ( Figure 2B ): Tlr4 (rank 10) and its co-receptors Ly96 (MD2) (rank 2) and Cd14 (rank 3); well-known members of LPS/Tlr4 signaling, including Ticam2 (TRAM, rank 5), Ticam1 (TRIF, rank 8), Myd88 (rank 4), Tirap (rank 9), and Traf6 (rank 13); Rela (rank 11), a component of NF K B, which regulates Tnf transcription; and two regulators of NF K B: Ikbkb and Ikbkg (NEMO) (rank 23 and rank 84, respectively). Other notable known regulators of the immune response and DC function include the DC pioneer transcription factor Cebpb (rank 21), Akirin2 (rank 39), and Rnf31 (rank 42) and Rbck1 (rank 19), two subunits of the linear ubiquitin chain assembly complex (LUBAC) that tags NEMO and enables NFKB activation. Overall, the top 100 ranked genes were highly enriched for central genes in the LPS-to-Tnf pathway, as annotated by KEGG (13/35 annotated genes are in the top 100; p = 10 À22 , hypergeometric test) ( Figure 1E ).
Dozens of Positive Regulators Identified by the Screen Validated Using Individually Cloned sgRNAs
To validate the top genes in the ranked list, we next tested two to three sgRNAs against each of the top 176 (112 positive and 64 negative) ranked candidate regulators in individual, rather than pooled, assays, along with 53 non-targeting controls. We measured intracellular Tnf levels by flow cytometry (Figure 2A ), excluding sgRNAs with significant reduction in viability (Table  S2 and Experimental Procedures). Overall, we verified 57 positive regulators out of 112 tested: 45 with at least two independent sgRNAs and another 12 genes with one sgRNA ( Figure 2C and Table S1 ), including key known regulators ( Figure 2B , right). The rate of true-positive regulators was in agreement with our predicted FDR ( Figure 2E ), and the effect size of TNF phenotype was well correlated with the original ranking ( Figure 2D ), supporting the accuracy of our statistical framework. Notably, 27 out of 57 validated genes are not previously annotated for immune function or Tnf regulation (e.g., Midn; Experimental Procedures and Table S1 ).
We explored the basis for false negatives among the positive regulators by examining 15 known regulators of LPS activation that were not among the top 100 ranked genes in the screen. Using 28 additional sgRNAs, we found that 8 of the 15 known regulators indeed reduced Tnf levels (Figures S2A and S2B; notably, these eight were better ranked in the original screen 417) than the remaining seven genes (2, 314) , demonstrating that some factors outside of our threshold still have functional impact in this complex response. (legend continued on next page)
Optimized Characterization of Novel Negative
Regulators by Analysis at Unsaturated Levels of Tnf Only 4 of 64 ( Figure S2C and Table S1 ) putative negative regulators were initially validated by two independent sgRNAs, including: Zfp36 (rank 1 among the ZS negative regulators; Figure 1A) , Stat5b (rank 9), Pdcd10 (CCM3, rank 32), and Ppp2r1a (rank 16). Each of these, including Zfp36, our known control, associates with human disease. Stat5b, a transcription factor activated in response to cytokine induction (Darnell, 1997) , is important for DC differentiation (Sebastiá n et al., 2008) (consistent with a low-Cd11c phenotype in its targeted cells; Figure S2E ) but was not previously implicated in regulation of Tnf. Pdcd10 (CCM3) was not previously reported to regulate Tnf and is associated with familial cerebral cavernous malformation (CCM) (Faurobert and Albiges-Rizo, 2010) , a vascular pathological condition. Pdcd10 (CCM3) was also found to physically interact with Ppp2r1a, the fourth negative regulator (Goudreault et al., 2009) . Interestingly, Calyculin A, a drug that inhibits the protein phosphatase 1 and protein phosphatase 2A complexes, of which Ppp2r1a is a member, was previously shown to induce Tnf secretion (Boehringer et al., 1999) . The small proportion of validated negative regulators and their relatively subtle phenotype suggested that our screen, conducted with a high (100 ng/ml) LPS concentration that leads to near-saturated Tnf levels, may be less sensitive for further induction of Tnf when perturbing negative regulators. To increase sensitivity for negative regulators, we reduced LPS by 5-fold and observed higher Tnf for 24 of 37 (65%) retested sgRNAs targeting 22 genes, including the translation initiation factor Eif5 not previously associated with TNF regulation, and the Rela-homolog DNA-binding protein Dnttip1 (TdIF1) (Yamashita et al., 2001 ) ( Figure S2D ). While this test is different from the initial screen and thus cannot assess its FDR, it does provide additional functional regulators.
A Deeper Secondary Pooled Screen Uncovers Additional Regulators with Greater Sensitivity and Specificity
To reduce false negatives due to limited cell numbers relative to the size of the sgRNA library or to sgRNA design, we performed a secondary pooled screen targeting 2,569 of the top genes (Table S5 ) from the genome-wide screen with 10 sgRNAs per gene (using the improved design of Doench et al. [2014] ) and 4.9-fold more cells per sgRNA. The secondary screen showed greater specificity and sensitivity, as reflected in enrichment of the known regulators ( Figures S2F and S2G ), highly correlated ranking of hits from the Z score and DE analyses ( Figure S2H and Table S1 ), and reduced FDR compared to the genomewide screen (e.g., FDR = 6.7% for top 100 genes, Figure S2I ), indicating a reduction in noise and enrichment for true positives. The hits included: Irak4 (ranked 9 in the secondary screen versus 187 in the primary screen), Irak1 (60 versus 992), Sharpin (another subunit of the LUBAC complex, ranked 36), and Nedd8 (ranked 52) and its E2 conjugation enzyme, Ube2f (ranked 25). In the secondary screen, we found 19 positive regulators with no immune annotation that were not found in the primary screen (Z > 1.5; FDR = 0.094; Table S1 ; e.g., Gpatch8). A deeper secondary screen is thus an effective strategy for increasing the rate of true positives when it is not feasible to expand the primary screen.
Positive Tnf Regulators Are Organized in Functional Modules by Their Impact on RNA and Protein Expression While all of the validated regulators affect Tnf levels, the pathways and mechanisms through which they act may be distinct. To help determine those, we first measured the impact of the validated positive regulators on the expression of four additional protein markers (Experimental Procedures), each reflecting distinct facets of DC biology: Cd11c (the defining surface marker of BMDCs), Cd14 (a Tlr4 co-receptor), Mip1a (an induced chemokine), and Il6 (an induced inflammatory cytokine). We statistically tested the effect of each sgRNA on protein expression compared to a set of six to eight non-targeting controls (Figure S3A and Experimental Procedures) and then grouped genes based on the similarity of their effects ( Figures 3A, 3B , and Table  S2 ). Notably, the Tnf distribution varied from unimodal to bimodal across different targeted genes ( Figure 2B) ; sequencing several target genes showed that, in some but not all cases, this could be explained by the proportion of edited cells ( Figures  S4A-S4C) .
The genes are largely partitioned into three major modules ( Figure 3A) . Module I consisted of sgRNAs targeting 17 genes, including 9 canonical regulators validated in the screen, each reducing the levels of Cd14 and Il6, but not Cd11c (Figures  3A-3C and Table S2 ), consistent with the roles of the known regulators in LPS signaling. Additional module members ( Figure 3A ) included: Ctcf, previously implicated in DC differentiation and activation (Koesters et al., 2007) and Tnf expression (Nikolic et al., 2014) , and the miRNA mmu-mir-106a, a member of the microRNA-17/20a family. Module II included nine regulators whose sgRNAs reduced all four proteins, among them: four subunits of the OST protein glycosylation complex (see below), Alg2, a glycosyltransferase involved in oligosaccharide synthesis (Haeuptle and Hennet, 2009; Huffaker and Robbins, 1983) , and genes whose molecular functions are currently unknown, such as Tmem258 ( Figure 3A) . Module III consisted of sgRNAs targeting three subunits of the PAF complex and Pol2rg; each reduced Cd11c and Il6 expression but had a very minor, albeit consistent, effect on Mip1a (Figures 3B and 3C ) and no effect on CD14. Some genes were not part of the three modules, including Midn, which is encoded in a locus associated with ulcerative colitis (based on GWAS studies; Beck et al., 2014) but has no known molecular function. Regulators in each of the modules may affect Tnf levels through mechanisms that are shared by members of the same module but are distinct from those of the other modules. To further assess this, we next measured with RNA-seq the global effects of each regulator on mRNA levels at 0, 2, 4, and 6 hr post-LPS (without Brefeldin), compared to 12-14 non-targeting sgRNAs per time point (Figures 3D-3F , S3B-S3E, and Experimental Procedures). Grouping regulators into modules based on similarity in their profiles, we found that the modules change over time, with the distinctions sharpened earlier in the response and diminishing at later time points as they converge through likely indirect effects. Pre-LPS (t = 0 hr, Figure 3D ), most regulators show little effect compared to non-targeting controls, except for one group consisting almost entirely of members of the OST complex, as well as Alg2 and Tmem258. At 2 and 4 hr ( Figures 3E and 3F ), the regulators partition to several modules, including the known TLR regulators, a PAF complex module, and a module associated with RNA regulators including Akirin2, Polr2g, and Pabpc1. Perturbation of the genes in the latter module reduces (p < 0.001) the expression of genes involved in immune effector processes and reduces regulation of immune system processes (GOrilla qFDR 0.0377 and 0.0246, respectively, at t = 2 hr; Table S3 ). By 6 hr ( Figure S3E ), the transcriptional effect of most regulators is more similar. Notably, addition of Brefeldin in these profiling experiments does not affect Tnf expression, suggesting that the effect of gene perturbation in the screen versus the profiling experiment is comparable for inflammatory gene expression ( Figure S3F ).
Taken together, our data suggest three key modules that impact Tnf levels in distinct ways. We next explored these, focusing on the modules of the OST and PAF complexes.
Components of the OST Complex and the ER Folding and Translocation Pathway Are Important for Tnf Expression in Response to LPS
Among the 57 genes that were confirmed individually were four structural subunits of the nine-protein oligosaccharyltransferase complex (OSTc): Dad1, Ddost/OST48, Rpn1, and Rpn2. Consistent with their physical association, they were all members of the same protein-and RNA-defined modules ( Figures 3A and 3D-3F ). The ER-resident OSTc tags asparagine residues of newly translated proteins with oligosaccharide chains that are critical for protein folding and transport through the ER. At least six other genes essential for the ER transport pathway (Alg2, Srpr, Srp54c, Sec61, Hsp90b, and Sec13; Figure 4A ), upstream or downstream of OSTc, were also among the top-ranking validated positive regulators (although not necessarily in the OSTc module).
More than 2,300 proteins are known to be N-glycosylated (Zielinska et al., 2010) , and knocking out subunits of OSTc may affect Tnf levels directly or indirectly and-in either case-could reflect a more global effect on N-glycosylated proteins and cell phenotype in LPS-stimulated BMDCs. Since both Ly96 and Tlr4 are N-glycosylated and Tlr4 transport to the membrane is disrupted in the absence of tagged asparagines (da Silva Correia and Ulevitch, 2002), we hypothesized that OSTc could affect Tnf levels by impacting Tlr4 and/or its signaling. Indeed, targeting any of the four OSTc structural subunits or Alg2 (Figures 3C and S4D ) strongly reduced each of the four protein markers (Figure 3A) , including CD11c. This general reduction is consistent with either of two hypotheses: (1) the cells are not properly differentiated, or (2) the cells have differentiated properly but their LPS sensing is compromised. In the latter case, OSTc mutants could have either (a) a global signaling defect (e.g., due to a lack of key membrane receptors) or (b) a more specific regulatory effect.
To distinguish between these hypotheses, we examined the specific genes whose expression is affected in OSTc-targeted cells, compared to cells targeted by known regulators from the TLR pathway, or in cells with non-targeting sgRNA controls, either before or after LPS stimulation . A global differentiation defect should be apparent in genome-wide expression profiles pre-LPS, and a global LPS signaling defect would be apparent post-LPS, while a specific regulatory effect would be manifested as a more specific transcriptional signature.
Pre-LPS ( Figure 4B ), there were few transcriptional differences between cells in which OSTc is targeted or not (Table  S3) , except for a group of 60 OST-induced genes that are enriched for the ER stress response (FDR q value = 5.83 3 10 À16 , GOrilla). Furthermore, 42 (p < 10 À10 , hypergeometric test) of these genes are bound by the transcription factor XBP1 at their proximal promoter in bone-marrow-derived macrophages (M. Artomov, L. Glimcher, and A.R., unpublished data and Cubillos- Ruiz et al., 2015) . Thus, OSTc perturbation has a limited and unique pre-LPS effect on ER stress response genes, and the reduction in CD11c is not associated with a differentiation defect. Notably, N-glycosylation and ER stress were previously shown to interact with the TLR pathway (Komura et al., 2013; Martinon et al., 2010) ; however, direct involvement of OSTc was not shown. The LPS response in DCs has been previously characterized (Shalek et al., 2014) by three distinct co-expression signatures: (1) anti-viral genes (''anti-viral''), (2) inflammatory genes, including Tnf, whose expression peaks at 2 hr (''peaked inflammatory''), and (3) inflammatory genes with sustained expression within the 6 hr timescale (''sustained inflammatory''). While several of the mutants in the known TLR pathway genes were defective in activating all three signatures ( Figures 5C-5E ), targeting OSTc members reduced the inflammatory signatures (sustained: p = 0.01; peaked: p = 0.01, t test), but not the anti-viral signature (p = 0.24, t test) ( Figures 4B-4E and 5C-5E), suggesting a specific rather than global effect on the Tlr4 response.
Additional regulators with the same profile as OSTc may regulate Tnf through related pathways. These include Hsp90b and Alg2, known members of the protein folding and secretion pathways ( Figure 4A and Figure S4D ) and Tmem258, whose human ortholog resides in a locus associated with Crohn's disease (Franke et al., 2010) and targeted by ANRIL, a long non-coding RNA associated with immune and metabolic diseases (Bochenek et al., 2013) . Targeting of Tmem258 induced the same ER stress genes pre-LPS (5/14 genes; 7.7 3 10 À5 q-FDR GOrilla; Table S3 ) and similar profiles post-LPS.
The PAF Complex and Its Physical Interactors Form a Module that Positively Regulates Tnf Protein Expression
Five of six known subunits of the PAF complex (PAFc; Paf1, Ctr9, Wdr61, Rtf1, Leo1), a regulator of transcription elongation and 3 0 mRNA processing (Jaehning, 2010) , were identified as positive regulators of Tnf expression among the top 100 ranked genes in the primary screen; each was validated individually (Figures 3C,  5A , 5B, and S5A), did not significantly affect cell proliferation (data not shown), had a similar effect on RNA and protein expression, and associated most strongly with a single module (Figure 3,  blue) . The sixth subunit, Cdc73 (rank 842 in the primary screen), was likely a false negative since two additionally designed sgRNAs did reduce Tnf expression ( Figure S5B ). The Ash2l subunit of the MLL complex, previously reported to physically interact with Cdc73 (Rozenblatt-Rosen et al., 2005) , was also validated as a positive regulator of Tnf in our screen (rank 41, Figure S5B ).
Regulation of transcription elongation was previously shown to be an important key step in the DC transcriptional response (Beaudoin and Jaffrin, 1989; Hargreaves et al., 2009 ). Prior studies have implicated Paf1 or PAFc in regulation of antiviral gene expression (Marazzi et al., 2012) , but PAFc was not previously implicated in Tnf or inflammatory gene expression.
To decipher the specific impact of PAFc, we examined its effect on each of the transcriptional signatures. Targeting PAFc subunits significantly reduces the expression of the anti-viral and sustained inflammatory signatures (p = 0.0002 and 0.001, respectively, t test) and has a weaker, albeit significant (p = 0.01), effect on the peaked inflammatory signature, including on Tnf mRNA ( Figures 5C-5F ).
To better understand PAFc's function, we analyzed PAFc interactors by immunopurification of Paf1 from BMDCs followed by mass spectrometry (MS) ( Figure 5G and Table S4 ). We re-identified all known complex components, except Rtf1, and identified interactions with several RNA-processing factors (Table S4) , including the AU-rich RNA-binding and leucine metabolism protein AUH (Kurimoto et al., 2009; Nakagawa et al., 1995) , an interaction confirmed by western blot ( Figure S5E ). Using an individual sgRNA targeting Auh (Figure 5H ), we found significant reductions in Tnf levels, whereas Srsf1 did not affect Tnf levels ( Figure S5D ). Since AUH binds AU-rich motifs in 3 0 UTRs and the stability of the Tnf transcript is known to be regulated through an AU-rich motif by three other RNA-binding proteins (AUF1 [Khabar, 2010] , Zfp36 [Carballo et al., 1998 ], and HuR [Dean et al., 2001; Tiedje et al., 2012] ), it would be interesting to test whether AUH also interacts with the 3 0 UTR of Tnf directly to regulate RNA levels. Although Rtf1 interacts with Paf1 in lower organisms (Mueller and Jaehning, 2002) , we did not observe a direct interaction between PAFc and Rtf1 when immunopurifying either Paf1 ( Figure 5G ) or Rtf1 ( Figure 5I and Table S4 ). Of four Rtf1 interactors tested (Git1, Git2, Arhgef6, and Irf4), only one, Irf4, significantly reduced Tnf expression ( Figure 5J ), consistent with its ranking in the secondary screen (rank 13). We also found that Irf4 affects Cd11c ( Figure S5C ), consistent with previous findings (Lehtonen et al., 2005; Tussiwand et al., 2012) . The interaction between Irf4 and Rtf1 may suggest that PAFc, Rtf1, and other accessory proteins can perform immune-specific transcriptional activation by recruiting sequence-specific transcription factors.
DISCUSSION
We developed a genome-wide genetic screen in primary cells, based on our previous demonstration that the genomes of BMDCs from Cas9-expressing mice could be edited effectively within a relatively short time window ex vivo (Platt et al., 2014) . By focusing on a quantitative cellular marker rather than cell viability, we illustrate the versatility of pooled screens and provide an effective approach for screening in primary cells derived from the Cas9 transgenic mouse. Our secondary pooled screen illustrates how increases in the number and efficacy of sgRNAs per gene and number of cells infected per sgRNA can substantially improve the specificity and sensitivity of a pooled screen. We thus employed a strategy that uses the results of the primary screen with a relatively permissive FDR threshold to then guide both a large number of individual sgRNA validation experiments and a secondary screen with a much lower FDR. Using these approaches, we systematically identified previously unrecognized regulators of Tnf in response to LPS, including two conserved protein complexes and many others (e.g., Tti2, Ruvbl2, Tmem258, Midn, Ddx39b, Stat5b, and Pdcd10) .
To determine whether the genes that affect Tnf act through different cellular pathways, we quantified how these regulators alter expression of additional protein markers and genomewide mRNAs and partitioned the regulators into three modules that are dominated by known Tlr4 pathway components, the OST complex or the PAF complex (Figure 3) , thus providing clues for the functions of genes within each module. While we do not yet have a molecular model for how OSTc and PAFc impact the TLR pathway, we found that targeting subunits of the OSTc results in baseline ER stress that is likely regulated by XBP1 and may contribute to the reduction in TNF response (Cubillos-Ruiz et al., 2015) . Our unbiased approach reveals how conserved cellular processes can have relatively specific effects on a well-defined response, offering a more comprehensive and unified view of how cellular functions are linked within a cell.
Our genome-wide, unbiased approach allowed us to uncover new modules and factors even in a heavily investigated immune pathway and will be useful across diverse biological systems, especially when coupled with advances in single-cell profiling that bridge the gap between genome-wide pooled screens and deep molecular readouts.
EXPERIMENTAL PROCEDURES
For full methods see, see the Supplemental Experimental Procedures.
Pooled Genome-wide CRISPR Screens
For the pooled genome-wide CRISPR screen, BMDCs were isolated from 6-to 8-week-old constitutive Cas9-expressing female mice and used as described previously (Platt et al., 2014) . Cells were infected with the pooled lentiviral library at an MOI of 1 at day 2. At day 9, BMDCs were stimulated with 100 ng/ml LPS, and after 30 min, Brefeldin A (GolgiPlug, BD Biosciences) was added. After 8 hr of LPS stimulation, cells were harvested, fixed, and stained for Tnf (Ramirez-Ortiz et al., 2015) and Cd11c and then FACS sorted (Supplemental Experimental Procedures). The genome-wide screens were performed as three independent replicates; in the first screen, 60 million infected cells yielded 350 million cells at day 9, while in the second and third screens, 200 million infected cells yielded 1 billion BMDCs at day 9. The secondary pooled screen (using a reduced library) was done using the same protocol with 200 million infected cells. For individual sgRNA experiments, we used a similar protocol, except BMDCs were infected with high MOI and selected with puromycin (Invitrogen).
Cloning of Individual and Libraries of sgRNAs and Subsequent Viral Production
For the primary screen, we used the GeCKOv2mouse library in the lentiGuidePuro vector . For the secondary screen, we designed 10 sgRNAs per gene to target 2,569 of the top genes (Table S5) in the DE analysis of the primary screen and added 2,500 non-targeting sgRNAs (Table S5) . For library construction, we used a previously published protocol . For individual sgRNA cloning, pairs of oligonucleotides (IDT) with BsmBI-compatible overhangs were separately annealed and cloned into the lentiGuide-Puro plasmid (also available at Addgene, plasmid #52963) using standard protocols. Lentivirus was made using 293T cells transfected with lentiGuide-Puro, psPAX2 (Addgene 12260), and pMD2.G (Addgene 12259) at a 10:10:1 ratio, using Lipofectamine LTX and plus reagents according to the manufacturer's instructions.
Amplification and Sequencing of sgRNAs from Cells
After sorting, DNA was purified using QIAGEN DNeasy Blood & Tissue Kit according to the manufacturer's instruction. PCR was performed as previously described , and the PCR products were sequenced on a HiSeq 2500. The reads were aligned to the sgRNAs using Bowtie 1 (Langmead et al., 2009 ).
Analysis of Screen
To score sgRNAs and genes based on their abundance in the different bins, we used two strategies: in the first (DE), we normalized the raw reads and averaged on all the sgRNAs per gene and then performed differential expression analysis on three biological repeats using the R package DESeq2 (Love et al., 2014) , which fits a negative binomial generalized linear model (GLM). In the second strategy (ZS), we combined all low and high bins from the three experiments into a single pair of TNF low and TNF hi bins, and fold changes of TNF low /TNF hi were Z score normalized. To collapse to gene level, the mean of the top four ranked sgRNAs was taken for positive regulators and the bottom four ranked sgRNAs for negative regulators. For the secondary screen, we used all sgRNAs in both methods. All of the ranks in the paper are based on ZS unless otherwise noted.
Analysis of Protein and RNA Expression
Day 9 differentiated and transduced BMDCs were activated with LPS for 0, 2, 4, and 6 hr for the RNA-seq experiments or for 8 hr before staining with Il-6, MIp1a, CD11c, and CD14 antibody. Cells with gene-specific sgRNAs were compared to those with non-targeting sgRNAs. For RNA purification, we used QIAGEN RNAeasy 96 Kit and constructed RNA libraries using the SMART-seq2 protocol (Picelli et al., 2013) in a 96-well plate format followed by Nextera XT DNA Sample Preparation (Illumina) and deep sequencing on a HiSeq 2500.
Protein Immunopurification
For each IP, 20 million unstimulated BMDCs were used. Each Paf1 or Rtf1 IP was always performed in parallel to a control IP and in two independent replicates. In one replicate of the experiment, the digested proteins were labeled with iTRAQ, and in the second replicate, they were labeled with TMT10plex.
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